FGFR3 mutations were significantly associated with lower pT stage, tumor grade, absence of carcinoma in situ, pN0, low level of p53, and longer disease-specific survival (DSS) based on an analysis of 1000 bladder cancer resection specimens13. The gene discussed is FGFR3; the disease is neoplasm.